Commonwealth Bank of Australia’s Bristol-Myers Squibb BMY Stock Holding History

Commonwealth Bank of Australia’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-130,779	Closed	-$5.92M	–	141
2019 Q2	$5.92M	Sell	130,779 -29,384	-18%	-$1.37M	0.06%	206
2019 Q1	$7.63M	Buy	160,163 +28,799	+22%	+$1.43M	0.07%	169
2018 Q4	$6.82M	Buy	131,364 +15,466	+13%	+$831K	0.08%	174
2018 Q3	$7.19M	Buy	115,898 +7,500	+7%	+$445K	0.07%	184
2018 Q2	$5.99M	Buy	108,398 +19,108	+21%	+$1.03M	0.06%	194
2018 Q1	$5.64M	Sell	89,290 -13,457	-13%	-$866K	0.06%	199
2017 Q4	$6.29M	Buy	102,747 +29,363	+40%	+$1.84M	0.06%	208
2017 Q3	$4.67M	Buy	73,384 +25,026	+52%	+$1.46M	0.05%	239
2017 Q2	$2.69M	Buy	48,358 +30,810	+176%	+$1.68M	0.03%	315
2017 Q1	$954K	Buy	17,548 +14,784	+535%	+$811K	0.01%	505
2016 Q4	$161K	Sell	2,764 -410	-13%	-$22.4K	﹤0.01%	595
2016 Q3	$171K	Hold	3,174	–	–	﹤0.01%	590
2016 Q2	$234K	Sell	3,174 -73	-2%	-$5.16K	﹤0.01%	582
2016 Q1	$208K	Sell	3,247 -47,240	-94%	-$2.98M	﹤0.01%	601
2015 Q4	$3.47M	Sell	50,487 -56,675	-53%	-$3.75M	0.04%	224
2015 Q3	$6.34M	Buy	107,162 +175	+0.2%	+$11.1K	0.08%	163
2015 Q2	$7.12M	Sell	106,987 -8,866	-8%	-$584K	0.09%	136
2015 Q1	$7.47M	Sell	115,853 -1,800	-2%	-$113K	0.1%	130
2014 Q4	$6.95M	Sell	117,653 -26,947	-19%	-$1.52M	0.1%	130
2014 Q3	$7.4M	Sell	144,600 -500	-0.3%	-$25K	0.1%	145
2014 Q2	$7.04M	Sell	145,100 -996,520	-87%	-$49.1M	0.09%	143
2014 Q1	$59.3M	Buy	1,141,620 +480,260	+73%	+$25.6M	0.38%	67
2013 Q4	$35.2M	Sell	661,360 -11,647	-2%	-$593K	0.24%	102
2013 Q3	$31.1M	Sell	673,007 -100,950	-13%	-$4.43M	0.23%	100
2013 Q2	$34.6M	Buy	+773,957	New	+$33.6M	0.26%	100

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Bank of Australia's BMY Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 130,779 shares — an estimated $5.92M sold.

Commonwealth Bank of Australia first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $59.3M in Q1 2014. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 130,779 Bristol-Myers Squibb shares in Q3 2019, an estimated $5.92M.
Commonwealth Bank of Australia first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
Commonwealth Bank of Australia's Bristol-Myers Squibb position peaked at $59.3M in Q1 2014.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.